Clinical Trial at Scripps Paves Way for More Patients to Benefit from Minimally Invasive Heart Valve Procedure

A recent San Diego Union-Tribune article highlighted Scripps Health’s participation in an important clinical trial that paves the way for more people to benefit from a minimally invasive heart valve replacement procedure as an alternative to open-heart surgery.

Paul Teirstein, MD, an interventional cardiologist at Scripps Clinic, discussed the catheter-based procedure, known as transcatheter aortic valve replacement or TAVR, and its expected expansion to healthier, lower-risk patients who, under current guidelines, must undergo heart surgery to get a new valve.

Read the story in The San Diego Union-Tribune: Octogenerarian weightlifter embraces alternative to open heart surgery.